MAPT and Hyperglycemia: a.)transgenic mice (hTau), tau knockout mice (Tau KO), and C57BL/6J mice (C57), which showed similar fasting blood glucose levels (Fig. 1A), were treated with intraperitoneal injection of STZ (150 mg/kg) to induce the hyperglycemia phenotype.